Spartan Planning & Wealth Management

Position in JNJ — Johnson & Johnson

CIK 1749283 GREENSBORO, NC

Position in JNJ

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$1,322,929

-$37,868 QoQ

Shares Held

5,209

-6.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.26%

of 13F equity value

Holder Rank

#2,717

of 4,664 holders

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Spartan Planning & Wealth Management holds $4,749,293 across 5 Drug Manufacturers - General names. JNJ ranks #2 (27.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,490	$1,787,150
2	JNJ	Johnson & Johnson This page	5,209	$1,322,929
3	ABBV	AbbVie Inc.	2,630	$661,813
4	MRK	Merck & Co., Inc.	4,853	$623,610
5	AMGN	Amgen Inc	977	$353,791

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,322,929	5,209	-6.4%	Shares	Sole	2026-07-22
2026-03-31	$1,360,797	5,567	+15.4%	Shares	Sole	2026-04-16
2025-12-31	$998,740	4,826	+4.3%	Shares	Sole	2026-01-08
2025-09-30	$858,123	4,628	+13.2%	Shares	Sole	2025-10-14
2025-03-31	$677,953	4,088	+159.6%	Shares	Sole	2025-04-08
2022-12-31	$278,223	1,575	-28.4%	Shares	Sole	2023-02-01
2022-06-30	$390,344	2,199	+59.1%	Shares	Sole	2022-08-10
2022-03-31	$244,931	1,382	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.